BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 30, 2010
View Archived Issues
Multiple Survival Screening: A new algorithm to predict low-risk breast cancer
Read More
Clinical data presented on DiaPep-277 in type 1 diabetes
Read More
Scientists describe CFTR inhibitors for acute secretory diarrhea
Read More
VP-20621 generally well tolerated in phase I study
Read More
ARRY-502 well tolerated in phase I study
Read More
Prucalopride enters phase III trial in men with chronic constipation
Read More
Johnson & Johnson acquires Micrus Endovascular
Read More
Sanofi Pasteur to acquire VaxDesign
Read More
FDA approves Cobas AmpliPrep/Cobas TaqMan HBV test v2.0
Read More
Dana-Farber Cancer Institute and sanofi-aventis collaborate on oncology targets
Read More
New phase II OGX-427 trial begins in metastatic prostate cancer
Read More
CONQUER trial reveals benefits of phentermine/topiramate combination in obesity
Read More
GSK patents new voltage-gated Ca(V)2.2 calcium channel ligands
Read More
Amira Pharma files IND application with FDA for AM-152
Read More
KAI-4169 enters phase Ib trial for secondary hyperparathyroidism in ESRD
Read More
Pfizer discontinues phase III Sutent trial in castration-resistant prostate cancer
Read More
Galapagos starts phase II trial of GLPG-0259 in rheumatoid arthritis
Read More
Elixir Pharmaceuticals claims new ghrelin receptor modulators
Read More
Seroquel XL approved in U.K. as add-on therapy for major depressive disorder
Read More
Genta initiates new phase II trial of tesetaxel in advanced bladder cancer
Read More
UC claims new modulators of nAChR subunit alpha7 and GABA(A) receptors
Read More
Organon synthesizes novel serotonin 5-HT2C receptor modulators
Read More
Homopiperazine acethydrazide derivatives patented as oncolytic agents
Read More
Nippon Zoki discloses new histidine derivatives
Read More
